Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112142823B reveals a streamlined ZP-1609 synthesis reducing steps and enhancing purity for reliable API intermediate supply chains.
Patent CN116668C details a novel weak Lewis acid catalyzed cyclization for high-purity PDE4 inhibitor intermediates, offering significant cost and supply chain advantages.
Patent CN111606962A details a safe levonorgestrel synthesis avoiding lithium ammonia, offering high purity and yield for reliable API intermediate supply chains.
Patent CN115975057A enables high purity Cotadutide via fragment condensation and supported DMAP catalysis for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN104513182A details a safer synthetic route for Lurasidone intermediates offering enhanced supply chain stability and reduced toxic waste for global pharmaceutical manufacturers.
Patent CN104498510A enables enzymatic synthesis of atorvastatin side chain with superior stereoselectivity and scalable fermentation processes for global supply chains.
Novel fluorescent material with high quantum yield and large Stokes shift for biological detection and imaging solutions ensuring supply chain reliability.
Patent CN108863969A reveals mild Pd-catalyzed isoxazole synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Discover the novel 4-step synthesis of 16α-hydroxyprednisolone from patent CN111253457A. Achieve >99.5% purity with reduced costs and scalable pharmaceutical intermediate production.
Patent CN101200463B details a cost-effective D-glucose route for 4-thio-D-ribose intermediates, offering significant supply chain advantages over traditional L-lyxose methods.
Novel alkali-modified mesoporous molecular sieve catalyst replaces NaOH for high-yield, scalable Pemetrexed Disodium production with superior purity.
Novel route from D-glucose reduces cost for 4-thio-nucleoside intermediates. High purity scalable process for antiviral drug synthesis.
Patent CN108239091B details a robust chemical resolution for NLG919 precursors. This method offers high optical purity, recoverable reagents, and scalable manufacturing for pharmaceutical supply chains.
Patent CN108239091B details a novel chemical resolution for NLG919 precursors, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110564755B details a novel enzymatic route for (S)-3-phenyl-1,2-epoxypropane. Discover cost-effective, metal-free manufacturing solutions for high-purity API precursors.
Patent CN115109052B details a novel AIE compound synthesis offering enhanced purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel separation method for trans-1-2-cyclohexanediamine via patent CN117417259A. Enhances purity and supply chain efficiency for pharmaceutical intermediate manufacturing.
Advanced synthesis of loxoprofen metabolite avoids chromatography. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel method for preparing high-purity ertapenem sodium via controlled moisture hydrogenation, offering cost-effective manufacturing solutions.
Patent CN102643879B reveals microbial route for duloxetine intermediate. High purity, scalable production offers significant supply chain and cost advantages.